Amgen Earnings-Revenue Beat in Q2
2022.08.04 23:22
Budrigannews.com – Amgen (NASDAQ:AMGN) reported on Thursday second quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.65 on revenue of $6.59B. Analysts polled by Investing.com anticipated EPS of $4.39 on revenue of $6.53B.
Amgen shares are up 9% from the beginning of the year, still down 4.44% from its 52 week high of $258.45 set on April 11. They are outperforming the Nasdaq 100 which is down 18.44% from the start of the year.
Amgen shares gained 0.37% in after-hours trade following the report.
Amgen follows other major Healthcare sector earnings this month
Amgen’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
